These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 29894684)
1. Beta catenin is regulated by its subcellular distribution and mutant huntingtin status in Huntington's disease cell STHdhQ111/HdhQ111. Ghatak S; Raha S Biochem Biophys Res Commun; 2018 Sep; 503(1):359-364. PubMed ID: 29894684 [TBL] [Abstract][Full Text] [Related]
2. Micro RNA-214 contributes to proteasome independent downregulation of beta catenin in Huntington's disease knock-in striatal cell model STHdhQ111/Q111. Ghatak S; Raha S Biochem Biophys Res Commun; 2015 Apr; 459(3):509-14. PubMed ID: 25747711 [TBL] [Abstract][Full Text] [Related]
4. Copper enhances aggregational toxicity of mutant huntingtin in a Drosophila model of Huntington's Disease. Lobato AG; Ortiz-Vega N; Zhu Y; Neupane D; Meier KK; Zhai RG Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166928. PubMed ID: 38660915 [TBL] [Abstract][Full Text] [Related]
5. TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models. Hegde RN; Chiki A; Petricca L; Martufi P; Arbez N; Mouchiroud L; Auwerx J; Landles C; Bates GP; Singh-Bains MK; Dragunow M; Curtis MA; Faull RL; Ross CA; Caricasole A; Lashuel HA EMBO J; 2020 Sep; 39(17):e104671. PubMed ID: 32757223 [TBL] [Abstract][Full Text] [Related]
6. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model. van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347 [TBL] [Abstract][Full Text] [Related]
7. Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease. Yin X; Manczak M; Reddy PH Hum Mol Genet; 2016 May; 25(9):1739-53. PubMed ID: 26908605 [TBL] [Abstract][Full Text] [Related]
8. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors. Banerjee M; Datta M; Bhattacharyya NP Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155 [TBL] [Abstract][Full Text] [Related]
9. Identification of differentially expressed genes and regulatory relationships in Huntington's disease by bioinformatics analysis. Dong X; Cong S Mol Med Rep; 2018 Mar; 17(3):4317-4326. PubMed ID: 29328442 [TBL] [Abstract][Full Text] [Related]
10. Identification of a novel caspase cleavage site in huntingtin that regulates mutant huntingtin clearance. Martin DDO; Schmidt ME; Nguyen YT; Lazic N; Hayden MR FASEB J; 2019 Mar; 33(3):3190-3197. PubMed ID: 30423259 [TBL] [Abstract][Full Text] [Related]
11. Reduced mitochondrial complex II activity enhances cell death via intracellular reactive oxygen species in STHdhQ111 striatal neurons with mutant huntingtin. Okada N; Yako T; Nakamura S; Shimazawa M; Hara H J Pharmacol Sci; 2021 Dec; 147(4):367-375. PubMed ID: 34663519 [TBL] [Abstract][Full Text] [Related]
12. Cancer: From Wild-Type to Mutant Huntingtin. Thion MS; Humbert S J Huntingtons Dis; 2018; 7(3):201-208. PubMed ID: 29889077 [TBL] [Abstract][Full Text] [Related]
13. The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicity. Pan Y; Zhu Y; Yang W; Tycksen E; Liu S; Palucki J; Zhu L; Sasaki Y; Sharma MK; Kim AH; Zhang B; Yano H J Biol Chem; 2018 Jul; 293(30):11850-11866. PubMed ID: 29891550 [TBL] [Abstract][Full Text] [Related]
14. Full sequence of mutant huntingtin 3'-untranslated region and modulation of its gene regulatory activity by endogenous microRNA. Kim KH; Abu Elneel K; Shin JW; Keum JW; Seong D; Kwak S; Lee R; Gusella JF; MacDonald ME; Seong IS; Lee JM J Hum Genet; 2019 Oct; 64(10):995-1004. PubMed ID: 31296921 [TBL] [Abstract][Full Text] [Related]
15. Huntington's Disease Protein Huntingtin Associates with its own mRNA. Culver BP; DeClercq J; Dolgalev I; Yu MS; Ma B; Heguy A; Tanese N J Huntingtons Dis; 2016; 5(1):39-51. PubMed ID: 26891106 [TBL] [Abstract][Full Text] [Related]
16. Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain. Lim NK; Hung LW; Pang TY; Mclean CA; Liddell JR; Hilton JB; Li QX; White AR; Hannan AJ; Crouch PJ Hum Mol Genet; 2014 Aug; 23(15):4051-63. PubMed ID: 24634145 [TBL] [Abstract][Full Text] [Related]
17. The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington's disease. Wanker EE; Ast A; Schindler F; Trepte P; Schnoegl S J Neurochem; 2019 Nov; 151(4):507-519. PubMed ID: 31418858 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington's disease. Manczak M; Reddy PH Hum Mol Genet; 2015 Dec; 24(25):7308-25. PubMed ID: 26464486 [TBL] [Abstract][Full Text] [Related]
19. AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington's Disease Minipig Model. Evers MM; Miniarikova J; Juhas S; Vallès A; Bohuslavova B; Juhasova J; Skalnikova HK; Vodicka P; Valekova I; Brouwers C; Blits B; Lubelski J; Kovarova H; Ellederova Z; van Deventer SJ; Petry H; Motlik J; Konstantinova P Mol Ther; 2018 Sep; 26(9):2163-2177. PubMed ID: 30007561 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-124 targets CCNA2 and regulates cell cycle in STHdh(Q111)/Hdh(Q111) cells. Das E; Jana NR; Bhattacharyya NP Biochem Biophys Res Commun; 2013 Jul; 437(2):217-24. PubMed ID: 23796713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]